Grapefruit Usa Inc 's ability to collect accounts receivable sequentially worsen to 0.23, pointing to a challenging and on top of that deteriorating business climate for the Medical Laboratories industry. Grapefruit Usa Inc 's Accounts Receivable average collection period in the Sep 30 2022 quarter, has increased to 1587 days, from 424 days, in the Jun 30 2022 quarter.

If we take a look into Healthcare sector 635 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2022 from 3249 to 3854.

What is Receivable Turnover Ratio?
What is Grapefruit Usa Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GPFT Receivables Turnover Ratio	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Receivable Change	-91.96 %	-90.19 %	13.23 %	606.51 %	-
Y / Y Revenue Change	-98.07 %	-70.83 %	-98.39 %	-99.8 %	-88.25 %
Receivable Turnover Ratio (TTM)	0.23	0.86	0.91	2.27	8.4
GPFT's Total Ranking	# 3854	# 3249	# 3815	# 4167	# 4178
Accounts Receivable average collection period days	1577	426	401	161	43
Seq. Receivable Change	2.67 %	-91.96 %	-0.02 %	-2.52 %	25.2 %
Seq. Revenue Change	-87.69 %	325.88 %	159.53 %	-98.58 %	86.06 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 35
Healthcare Sector	# 636
Overall Market	# 3854

Receivable Turnover Ratio Statistics
High	Average	Low
106.83	21.91	-16.2
(Sep 30 2020)		(Sep. 30, 2014)

GPFT Company Profile • Back to GPFT Efficiency Comparisons • Compare GPFT Receivables Turnover Ratio to its Competitors

Financial Statements
Grapefruit Usa Inc 's Accounts Receivable	$ 0 Millions	Visit GPFT's Balance sheet
Grapefruit Usa Inc 's Sales TTM	$ 0 Millions	Visit GPFT's Income Statement
Sources of GPFT's Revenues		Visit GPFT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GPFT's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GPFT's Growth Rates	GPFT's Roa	GPFT's Inventory Turnover Ratio	GPFT's Dividend Comparisons
GPFT's Profitability Ratios	GPFT's Roi	GPFT's Asset Turnover Ratio	GPFT's Dividend Growth
GPFT's Valuation Ratios	GPFT's Roe	GPFT's Financial Strength Ratios	GPFT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2022	Receivable at quarter ending Sep 30 2022
Elanco Animal Health Incorporated	4.15	$ 4,543.000 Millions	$ 1,094.000 Millions
Ginkgo Bioworks Holdings Inc	4.12	$ 615.648 Millions	$ 149.461 Millions
Zymeworks Inc	4.11	$ 31.611 Millions	$ 7.692 Millions
Opiant Pharmaceuticals Inc	4.10	$ 22.338 Millions	$ 5.449 Millions
Aytu Biopharma Inc	4.09	$ 102.427 Millions	$ 25.060 Millions
Rapid Micro Biosystems Inc	4.08	$ 17.967 Millions	$ 4.400 Millions
Sunwin Stevia International Inc.	4.04	$ 33.998 Millions	$ 8.424 Millions
Rafael Holdings Inc	4.03	$ 2.124 Millions	$ 0.527 Millions
Bionik Laboratories Corp	4.01	$ 1.106 Millions	$ 0.276 Millions
Enanta Pharmaceuticals Inc	4.00	$ 86.160 Millions	$ 21.540 Millions
Inspiremd Inc	3.98	$ 5.299 Millions	$ 1.330 Millions
Bioventus Inc	3.97	$ 515.305 Millions	$ 129.864 Millions
Curis Inc	3.94	$ 10.410 Millions	$ 2.641 Millions
Pro dex Inc	3.93	$ 43.140 Millions	$ 10.990 Millions
Prophase Labs Inc	3.92	$ 145.980 Millions	$ 37.226 Millions
Athenex Inc	3.89	$ 119.706 Millions	$ 30.745 Millions
Kineta Inc	3.88	$ 4.845 Millions	$ 1.250 Millions
Pliant Therapeutics Inc	3.87	$ 9.719 Millions	$ 2.513 Millions
Innoviva Inc	3.85	$ 373.216 Millions	$ 97.063 Millions
Bellicum Pharmaceuticals Inc	3.81	$ 1.546 Millions	$ 0.405 Millions
Psychemedics Corporation	3.80	$ 25.973 Millions	$ 6.826 Millions
Signify Health Inc	3.75	$ 783.900 Millions	$ 209.300 Millions
Agile Therapeutics Inc	3.74	$ 8.402 Millions	$ 2.249 Millions
Barinthus Biotherapeutics Plc	3.71	$ 38.245 Millions	$ 10.314 Millions
Halozyme Therapeutics Inc	3.70	$ 580.623 Millions	$ 156.852 Millions
Paratek Pharmaceuticals Inc	3.70	$ 116.507 Millions	$ 31.483 Millions
Ligand Pharmaceuticals Incorporated	3.68	$ 241.673 Millions	$ 65.667 Millions
Eli Lilly And Company	3.66	$ 29,239.500 Millions	$ 7,982.525 Millions
Ironwood Pharmaceuticals inc	3.64	$ 420.527 Millions	$ 115.604 Millions
Royalty Pharma Plc	3.60	$ 2,247.167 Millions	$ 625.034 Millions

Date modified: 2026-06-22T14:32:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.